Sign in
4

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001104659-23-126020

Chief Executive Officer sold 1,820 shares at $2.50 ($4,550)

From the SEC's structured data for this filing

Trades in this filing

Alder Matthias · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-07 Sale : show line 1 in the form −1,820 $2.50 $4,550 4,855 D
Open-market sales · 1,820 sh · avg $2.50 · $4,550
Loading xslF345X05/tm2332941-1_4seq1.xml…